GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (FRA:0PQ) » Definitions » Short-Term Debt

ProQR Therapeutics NV (FRA:0PQ) Short-Term Debt : €4.51 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Short-Term Debt?

ProQR Therapeutics NV's Short-Term Debt for the quarter that ended in Sep. 2024 was €4.51 Mil.

ProQR Therapeutics NV's quarterly Short-Term Debt increased from Mar. 2024 (€4.37 Mil) to Jun. 2024 (€4.44 Mil) and increased from Jun. 2024 (€4.44 Mil) to Sep. 2024 (€4.51 Mil).

ProQR Therapeutics NV's annual Short-Term Debt declined from Dec. 2021 (€4.77 Mil) to Dec. 2022 (€2.50 Mil) and declined from Dec. 2022 (€2.50 Mil) to Dec. 2023 (€0.00 Mil).


ProQR Therapeutics NV Short-Term Debt Historical Data

The historical data trend for ProQR Therapeutics NV's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Short-Term Debt Chart

ProQR Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 1.14 4.77 2.50 -

ProQR Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.34 - 4.37 4.44 4.51

ProQR Therapeutics NV Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


ProQR Therapeutics NV Short-Term Debt Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


ProQR Therapeutics NV Business Description

Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

ProQR Therapeutics NV Headlines

No Headlines